With deaths from obesity-related heart disease reportedly increasing by 180% over the past 20 years, more research is being done to learn how GLP-1 medications such as Ozempic, Wegovy, Mounjaro and ...

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

The price of Wegovy, the diabetes control drug's glamorous anti-obesity sibling, may also be falling, according to a Health ...

Ozempic and other weight loss drugs make you lose muscle, too. Here's why that's not as bad as it sounds, but you should still work on building muscle, too.

While Ozempic bodes well for weight loss, some users are concerned the drug's impact also means unwanted changes to their ...

If you're in a relationship that faces struggles with weight and are considering GLP-1 medications like Ozempic, consider ...

For employers wanting to dip a toe into the GLP-1 medications pool, utilization management is recommended to control costs.

Ozempic — or any of the GLP-1 class of diet drugs that includes Wegovy and Mounjaro — hasn’t just changed our nation’s ...

Most people taking drugs like Ozempic and Wegovy have shed significant pounds. But obesity experts say that roughly 20% of ...

A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, ...

A proposal floated Tuesday by outgoing President Joe Biden to require Medicare and Medicaid to offer coverage for prescriptions of popular but expensive injectable weight loss drugs had the tentative ...